Search Results - "Genain, C"

Refine Results
  1. 1

    An open label study of the effects of rituximab in neuromyelitis optica by CREE, B. A. C, LAMB, S, MORGAN, K, CHEN, A, WAUBANT, E, GENAIN, C

    Published in Neurology (12-04-2005)
    “…Eight patients with worsening neuromyelitis optica were treated with rituximab to achieve B cell depletion. Treatment was well tolerated. Six of eight patients…”
    Get full text
    Journal Article
  2. 2

    Activity of a newly identified serine protease in CNS demyelination by SCARISBRICK, I. A, BLABER, S. I, LUCCHINETTI, C. F, GENAIN, C. P, BLABER, M, RODRIGUEZ, M

    Published in Brain (London, England : 1878) (01-06-2002)
    “…We have identified a novel serine protease, myelencephalon-specific protease (MSP), which is preferentially expressed in the adult CNS, and therein, is…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen-specific antibody mediation by Raine, Cedric S., Cannella, Barbara, Hauser, Stephen L., Genain, Claude P.

    Published in Annals of neurology (01-08-1999)
    “…Neuropathological and ultrastructural features of central nervous system demyelination were compared in marmoset experimental autoimmune encephalomyelitis…”
    Get full text
    Journal Article
  5. 5

    Late Complications of Immune Deviation Therapy in a Nonhuman Primate by Genain, Claude P., Abel, Kristina, Belmar, Nicole, Villinger, Francois, Rosenberg, Daniel P., Linington, Christopher, Raine, Cedric S., Hauser, Stephen L.

    “…The administration of antigens in soluble form can induce antigen-specific immune tolerance and suppress experimental autoimmune diseases. In a marmoset model…”
    Get full text
    Journal Article
  6. 6

    Identification of autoantibodies associated with myelin damage in multiple sclerosis by Genain, Claude P, Cannella, Barbara, Hauser, Stephen L, Raine, Cedric S

    Published in Nature medicine (01-02-1999)
    “…The molecular mechanisms underlying myelin sheath destruction in multiple sclerosis lesions remain unresolved. With immunogold-labeled peptides of myelin…”
    Get full text
    Journal Article
  7. 7

    Creation of a model for multiple sclerosis in Callithrix jacchus marmosets by GENAIN, C. P, HAUSER, S. L

    “…Multiple sclerosis (MS) is an inflammatory disease of the CNS white matter characterized pathologically by the accumulation of perivascular and parenchymal T…”
    Get full text
    Journal Article
  8. 8

    Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system by Villoslada, P, Hauser, S L, Bartke, I, Unger, J, Heald, N, Rosenberg, D, Cheung, S W, Mobley, W C, Fisher, S, Genain, C P

    Published in The Journal of experimental medicine (15-05-2000)
    “…Multiple sclerosis is a demyelinating disorder of the central nervous system (CNS), in which an immune attack directed against myelin constituents causes…”
    Get full text
    Journal Article
  9. 9

    Role of nerve growth factor and other trophic factors in brain inflammation by Villoslada, Pablo, Genain, Claude P

    Published in Progress in brain research (2004)
    “…Inflammation in the brain is a double-edged process that may be beneficial in promoting homeostasis and repair, but can also result in tissue injury through…”
    Get more information
    Journal Article
  10. 10

    Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis by Menge, Til, Lalive, Patrice H., von Büdingen, Hans-Christian, Cree, Bruce, Hauser, Stephen L., Genain, Claude P.

    Published in Journal of Allergy and Clinical Immunology (01-08-2005)
    “…Galactocerebroside, the major glycolipid of central nervous system myelin, is a known target for pathogenic demyelinating antibody responses in experimental…”
    Get full text
    Journal Article
  11. 11

    Specific immunotherapy: One size does not fit all by Genain, Claude P, Zamvil, Scott S

    Published in Nature medicine (01-10-2000)
    “…Two clinical trials testing an altered peptide ligand (APL) in multiple sclerosis report seemingly contradictory results. Immunologic analysis shows that the…”
    Get full text
    Journal Article
  12. 12

    Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis by Massacesi, L, Genain, C P, Lee-Parritz, D, Letvin, N L, Canfield, D, Hauser, S L

    Published in Annals of neurology (01-04-1995)
    “…A chronic relapsing-remitting form of experimental autoimmune encephalomyelitis was induced in the common marmoset Callithrix jacchus following a single…”
    Get more information
    Journal Article
  13. 13

    3-D echo planar (1)HMRS imaging in MS: metabolite comparison from supratentorial vs. central brain by Pelletier, D, Nelson, S J, Grenier, D, Lu, Y, Genain, C, Goodkin, D E

    Published in Magnetic resonance imaging (01-10-2002)
    “…To determine if metabolite ratios as measured by 3-dimensional echo planar spectroscopy imaging (3D-EPSI) from central brain regions of interest (ROI) centered…”
    Get full text
    Journal Article
  14. 14

    Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus by Genain, Claude P., Hauser, Stephen L.

    Published in Immunological reviews (01-10-2001)
    “…Models that adequately reflect the complexity of human multiple sclerosis (MS) are needed, especially for preclinical testing of immunomodulatory drugs. Our…”
    Get full text
    Journal Article
  15. 15

    Molecular Characterization of Antibody Specificities against Myelin/Oligodendrocyte Glycoprotein in Autoimmune Demyelination by von Büdingen, Hans-Christian, Hauser, Stephen L., Fuhrmann, Antje, Nabavi, Cameron B., Lee, Joy I., Genain, Claude P.

    “…Myelin/oligodendrocyte glycoprotein (MOG) is a target antigen for myelin-destructive Abs in autoimmune central nervous system demyelinating disorders. Little…”
    Get full text
    Journal Article
  16. 16

    Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate by Genain, C P, Nguyen, M H, Letvin, N L, Pearl, R, Davis, R L, Adelman, M, Lees, M B, Linington, C, Hauser, S L

    Published in The Journal of clinical investigation (01-12-1995)
    “…In the human disease multiple sclerosis (MS), the immune mechanisms responsible for selective destruction of central nervous system myelin are unknown. In the…”
    Get full text
    Journal Article
  17. 17

    Characterization of the expressed immunoglobulin IGHV repertoire in the New World marmoset Callithrix jacchus by von Büdingen, H C, Hauser, S L, Nabavi, C B, Genain, C P

    Published in Immunogenetics (New York) (01-09-2001)
    “…The common marmoset (Callithrix jacchus jacchus) is a member of the Callithrichinae, a family of outbred New World primates with limited MHC polymorphisms and…”
    Get full text
    Journal Article
  18. 18

    Cloning, sequencing, and homology analysis of nonhuman primate Fas/Fas-ligand and co-stimulatory molecules by Villinger, F, Bostik, P, Mayne, A, King, C L, Genain, C P, Weiss, W R, Ansari, A A

    Published in Immunogenetics (New York) (01-05-2001)
    “…The finding that a single administration of select recombinant human cytokines to nonhuman primates leads to potent cytokine-neutralizing antibody responses in…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Frequency, heterogeneity and encephalitogenicity of T cells specific for myelin oligodendrocyte glycoprotein in naive outbred primates by Villoslada, Pablo, Abel, Kristina, Heald, Nathan, Goertsches, Robert, Hauser, Stephen L., Genain, Claude P.

    Published in European journal of immunology (01-10-2001)
    “…Auto‐reactive T cells present in healthy subjects remain in a state of unresponsiveness, but may trigger autoimmunity under various situations. Although myelin…”
    Get full text
    Journal Article